When sulcal enhancement is not leptomeningeal metastasis: diagnostic value of T1–T2FLAIR matching for differentiating benign contrast leakage
European Journal of Radiology · 2026
DOI: 10.1016/j.ejrad.2026.112992 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Radiology, 2026. Verfasst von Leehi Joo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, the Republic of Korea. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Meningeal Neoplasms, Extravasation of Diagnostic and Therapeutic Materials, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Chung-Ang University.
Abstract (Originalsprache)
The incidence and imaging characteristics of non-neoplastic sulcal enhancement on contrast-enhanced T2-weighted fluid-attenuated inversion recovery (CE-T2FLAIR) imaging in routine neuro-oncologic magnetic resonance imaging (MRI) were investigated. Contrast-enhanced T1-T2FLAIR sequence matching was used to differentiate benign contrast leakage from leptomeningeal metastasis (LMS). This retrospective, single-center study included 337 patients who underwent contrast-enhanced brain MRI for evaluation of suspected intracranial metastasis. Sulcal enhancement on CE-T2FLAIR was classified as absent, contrast leakage, or LMS based on imaging and clinical criteria. Two neuroradiologists independently determined T1-T2FLAIR matching status. Overall, 271 showed no leptomeningeal enhancement; 55 patients demonstrated contrast leakage and were older than the other groups; 11 were accurately diagnosed with LMS. Using match positivity as the cutoff, sensitivity and specificity were 90.9% and 94.8%, respectively for the LMS diagnosis. Mismatch patterns were common in contrast leakage and associated with older age, higher cerebral microbleed burden, cortical superficial siderosis, and prior radiotherapy. Non-neoplastic sulcal enhancement on CE-T2FLAIR is a common finding in contemporary neuro-oncologic MRI, particularly with delayed post-contrast acquisition. Assessing agreement between CE-T2FLAIR and contrast-enhanced T1-weighted imaging provides a simple and robust method for distinguishing benign contrast leakage from LMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, the Republic of Korea.
- Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, the Republic of Korea. Electronic address: noiese@icloud.com.
Förderung
- Chung-Ang University
Zitieren
APA
Joo, L., Lee, J., & Yim, Y. (2026). When sulcal enhancement is not leptomeningeal metastasis: diagnostic value of T1–T2FLAIR matching for differentiating benign contrast leakage. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2026.112992
Vancouver
Joo L, Lee J, Yim Y. When sulcal enhancement is not leptomeningeal metastasis: diagnostic value of T1–T2FLAIR matching for differentiating benign contrast leakage. European Journal of Radiology. 2026. doi:10.1016/j.ejrad.2026.112992
BibTeX
@article{Joo2026,
author = {Joo, Leehi and Lee, Jungbin and Yim, Younghee},
title = {When sulcal enhancement is not leptomeningeal metastasis: diagnostic value of T1–T2FLAIR matching for differentiating benign contrast leakage},
journal = {European Journal of Radiology},
year = {2026},
doi = {10.1016/j.ejrad.2026.112992}
}
EUVIMED